Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: J Clin Lipidol. 2017 Mar 30;11(3):694–703. doi: 10.1016/j.jacl.2017.03.007

Table. 1.

Clinical characteristics of control and diabetic subjects involved in the circadian study.

Subject # Gender Age Diabetes duration HbA1C CVD Retinopathy Medications
Diabetic 1 Female 67 T2D 4 months 7.5 No No Glucophage
Diabetic 2 Female 65 T2D 20 years 8.8 No No Lantus
Diabetic 3 Male 76 T2D 7.4 No No Glucophage
Diabetic 4 Female 64 T2D 6.3 No No Actos
Diabetic 5 Female 67 T2D 6.4 No No Glucophage
Diabetic 6 Female 68 T2D 9 years 6.8 No No Diabeta
Diabetic 7 Female 48 T2D years 6.0 No No Metformin
Diabetic 8 Female 59 T2D 10 years 7.7 No No Humulin
Control 1 Female 43 No No
Control 2 Female 57 No No
Control 3 Female 68 No No
Control 4 Male 43 No No

Inclusion criteria: Individuals between the ages of 21 and 65 years were eligible to participate.

Exclusion criteria: Subjects were excluded for the following reasons: a) evidence of ongoing acute or chronic infection (HIV, Hepatitis B or C, or tuberculosis); b) ongoing malignancy; c) cerebral vascular accident or cerebral vascular procedure; d) current pregnancy; e) history of organ transplantation; f) presence of a graft; g) uremic symptoms, such as an estimated glomerular filtration rate of less than 20 cc/min (by Modification of Diet in Renal Disease equation), or an albumin of less than 3.6 (to avoid malnutrition as a confounding variable); h) a history of smoking; and i) anemia.